Behringwerke Aktiengesellschaft

Aventis Pharma Deutschland, Gmbh

Dade Behring Marburg Gmbh

Friedrich-Robert Seiler

Roland Kurrle

Karlheinz Enssle

Leander Lauffer

Klaus-Dieter Langner

Hans-Harald Sedlacek

Roloff Johannsen

Josef-Urban Pauly

The invention relates to a method for detecting and determining mediators and/or their derivatives in fluids, the mediator being detected directly or indirectly with the aid of a recombinant, soluble receptor for the mediator to be detected.

Method for detecting and determining mediators

Use of the IL-4 receptor for the therapy prophylaxis and diagnosis of allergic viral parasitic and bacterial diseases and of fungal infections

The IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections. The invention relates to the il-4 receptor or variants thereof for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections.

IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, and bacterial diseases and of fungal infections

The present invention relates to a composition containing the p40 subunit of interleukin-12, hereinafter referred to as p40/IL-12 and to methods of diagnosis and treatment of disorders associated with disregulation of the immune system.

Composition containing the P40 subunit of interleukin-12

A method for determininng a reagent capable of immunologic reaction by direct or indirect test methods, wherein an antigen is contacted with the Fc fragment of an immune globulin prior to contacting it with an antibody having no specificity to said Fc fragment, whereby unspecific linkages arre decreased.

Immunologic determination method

Growing community of inventors

Marburg, Germany

Friedrich-Robert Seiler